Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on deprotection optimization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113087712B discloses novel gliotoxin derivatives with superior LSD1 inhibition. Discover scalable synthesis for high-purity pharmaceutical intermediates.
Novel entecavir preparation method significantly reduces solvent usage and enhances purity for reliable pharmaceutical intermediate supply chain stability and cost efficiency.
Solve low yield and impurity issues in camptothecin synthesis. New deprotection method cuts solvent use, boosts purity to 99.9% and recovers mother liquor for cost savings.
Solve NMR imaging agent supply chain risks with this patent-validated synthesis. 92-96% yields, no toxic reagents, and 75%+ step recovery. Scale to 100MT/yr.